Patheon says OSC has ended probe into insider trading by execs

TORONTO (CP) - Pharmaceutical company Patheon Inc. said Thursday it has been told an Ontario Securities Commission probe into share trading by its CEO and chief operating officer is over. The company said it was informed by the OSC in a letter dated Dec....More